John leads the Patient Health & Impact Healthcare Innovation Center at Pfizer. His team designs new models of access and innovative financing, while partnering across the healthcare sector to improve the patient experience, population health and co-create shared value.

Dr. Doyle has published more than 50 peer-reviewed papers and serves as an Adjunct Assistant Professor of Epidemiology at Columbia University. John also serves as the Co-Chair of the Alliance for Regenerative Medicine Foundation’s Economic Impact Steering Committee, focused on building a value framework to assess the clinical, economic, humanistic, and social impact that cell and gene therapies will have on the healthcare economy.

John earned a Doctorate and Master of Public Health degree in Epidemiology from the Mailman School of Public Health at Columbia University and a Bachelor of Science degree in Business Management & Applied Economics at Cornell University.